scholarly journals Health state utility values among children and adolescents with disabilities: protocol for a systematic review

BMJ Open ◽  
2018 ◽  
Vol 8 (2) ◽  
pp. e019978
Author(s):  
Lucy Kanya ◽  
Nana Anokye ◽  
Jennifer M Ryan

IntroductionIncreasingly, assessment of healthcare technologies and interventions requires the assessment of both costs and utilities. Health state utility values (HSUVs) are measured using a range of generic and condition-specific measures. While reviews have identified that generic measures of HSUVs may lack validity in adults with conditions that result in physical disability, there is little information available on the methods used to obtain HSUVs in children and adolescents with disabilities. The objectives of this systematic review are to describe the methods used to obtain HSUVs, including mode of administration and psychometric properties, and provide summary statistics for HSUVs among children and adolescents with disabilities.Methods and analysisThe following databases will be searched from inception for English-language studies of any design: PubMed, PsychInfo, Medline, Scopus, CINAHL Plus, Econlit and EMBASE databases. Two reviewers will independently screen titles, abstracts and full text articles for studies reporting HSUVs and/or data on the psychometric properties of preference-based measures for children and adolescents with disabilities aged up to 19 years. Two reviewers will independently extract data items including descriptors of the study methods and sample, instruments used to capture HSUVs, summary statistics for HSUVs and items relating to the quality of reporting. A descriptive summary of results from included studies and summary statistics for HSUVs will be presented. If sufficient data is identified, we will pool summary statistics for HSUVs according to the method used to obtain the HSUV using a random effects model. In addition, we will explore the determinants of the HSUVs using a meta-regression.Ethics and disseminationEthical approval will not be required as no original data will be collected as part of this review. The completed review will be submitted for publication in a peer-reviewed journal and presentation at conferences.PROSPERO registration numberCRD42018086574.

Author(s):  
Ryan O’Reilly ◽  
Sayako Yokoyama ◽  
Justin Boyle ◽  
Jeffrey C. Kwong ◽  
Allison McGeer ◽  
...  

2019 ◽  
Vol 22 (4) ◽  
pp. 142-144 ◽  
Author(s):  
David Aceituno ◽  
Mark Pennington ◽  
Barbara Iruretagoyena ◽  
Matthew A Prina ◽  
Paul McCrone

IntroductionCost-effectiveness analyses that use quality-adjusted life-years (QALYs) allow comparing the value for money of interventions across different health problems. Health state utility values (HSUVs) are crucial to calculate QALYs. These are weights attached to a given health state reflecting preferences in health-related quality of life (HRQoL). In schizophrenia, there is extensive evidence about the consequences of this condition on HRQoL. Besides, several interventions have claimed to be cost-effective in terms of QALYs gained. Despite this evidence, a systematic review of HSUVs has not been conducted. Therefore, we aim to synthesise the evidence about HSUVs in schizophrenia.Methods and analysisWe will conduct a systematic review of the literature about HSUVs in people with schizophrenia following the Preferred Reporting Items for Systematic review and Meta-Analysis and the International Society for Pharmacoeconomics and Outcomes Research task force recommendations. The submissions records of eight electronic peer-reviewed databases and three health technology assessment (HTA) agencies will be searched. Quantitative synthesis will be carried out in comparable studies, using random-effects meta-analysis. Heterogeneity will be explored using meta-regression if more than 10 studies per covariate are found. A narrative synthesis and methodological quality of included studies will be also reported.DiscussionThis review will provide a synthesis of the HSUVs estimated for different states experienced by people with schizophrenia. This will inform analysts when calculating QALYs, using values in a more transparent and accountable manner. Finally, it will shed light on evidence gaps and limitations about this measure in mental health.PROSPERO registration numberCRD42019123582.


2016 ◽  
Vol 19 (7) ◽  
pp. A593 ◽  
Author(s):  
D Golicki ◽  
A Wójcik ◽  
K Młyńczak ◽  
I Dobrowolska ◽  
K Jaśkowiak ◽  
...  

2015 ◽  
Vol 4 (1) ◽  
Author(s):  
Christopher J Sampson ◽  
Jonathan C Tosh ◽  
Christopher P Cheyne ◽  
Deborah Broadbent ◽  
Marilyn James

2018 ◽  
Vol Volume 10 ◽  
pp. 83-92 ◽  
Author(s):  
Anna Forsythe ◽  
Patricia S Brandt ◽  
Mike Dolph ◽  
Sachin Patel ◽  
Adrian Paul J Rabe ◽  
...  

2014 ◽  
Vol 17 (7) ◽  
pp. A645
Author(s):  
I. Al-Dakkak ◽  
J. Borrill ◽  
E. Murphy ◽  
J. Posnett ◽  
Y. Zhang

Sign in / Sign up

Export Citation Format

Share Document